CSBR Champions Oncology: Company Short-Term Debts

Symbol and logo of brand Champions Oncology Corp (CSBR)

Champions Oncology generates revenue through personalized drug testing, creating a stable cash flow via contracts with pharmaceutical behemoths. Fluctuations in short-term debt, where 0.00 reflects the latest metric level, link this income to top management's efforts to expand partnerships. However, high maintenance costs for bio-models and the risk of biotech budget cuts for preclinical research pressure the overall business margins.

CSBR championsoncology.com Company Short-Term Loans and Borrowings (07/04/2022 - 11/01/2026)

CSBR (Champions Oncology Inc): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Champions Oncology Corp|CSBR - Consensus Target
- company stock capitalization data:
Market Capitalization Champions Oncology, Inc.|CSBR - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Champions Oncology|CSBR - Accounting Value of Company|Market Cap to Net Assets Ratio championsoncology.com|CSBR - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Champions Oncology|CSBR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Champions Oncology Corp|CSBR - Company Aggregate Debts|Debt to Book Capitalization Ratio Champions Oncology, Inc.|CSBR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Champions Oncology|Quick Ratio championsoncology.com
- earnings and multiples data:
CSBR - Net Income
Analysis of all company metrics:CSBR - championsoncology.com
Manufactured products of Champions Oncology

Steady demand for precision drug testing platforms strengthens the position of Champions Oncology (CSBR) within the preclinical research sector. By analyzing the dynamics of current liabilities, investors track short-term loans and their repayment, allowing for an objective assessment of profitability decline risks and the company's operational resilience amid volatile debt capital, independent of market sentiment.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts CTOR|Company Current Liabilities tuhurabio.com HURA|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Company Short-Term Loans and Borrowings FATE|Aadi Bio - Company Short-Term Debts|TCRX - Company Short-Term Debts|xbiotech.com (XBIT) - Company Short-Term Debt|Company Current Liabilities CEL-SCI|Company Short-Term Debt OS Therapies|Radiopharm Theranostics Ltd - Current Liabilities|Company Short-Term Debts ARTV|Short-Term Debt Volume adlainortye.com|Company Short-Term Debt Veru Inc. VERU|tempesttx.com (TPST) - Short-Term Debt|XLO - Company Short-Term Debt|RENB (Renovaro Inc.) - Company Short-Term Indebtedness|muraloncology.com (MURA) - Company Short-Term Debt|KAPA - Short-Term Debt Volume|Company Current Liabilities OKUR|GDTC: Company Short-Term Loans and Borrowings|Company Short-Term Debt Curis, Inc. (CRIS)|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|ADVB: Company Short-Term Indebtedness|Genprex, Inc. - Company Short-Term Debts|Calidi Biotherapeutics (CLDI) - Company Current Liabilities|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Short-Term Debt Xenetic Biosciences, Inc. (XBIO)|Company Short-Term Debt Salarius|Company Short-Term Debt PPBT|Company Short-Term Debt American Oncology Network (AONC)|BGNE - Short-Term Debt|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Short-Term Indebtedness Elevation Oncology Inc.|ICAD: Company Current Liabilities|Short-Term Debt Ikena Oncology, Inc.|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Short-Term Debt MorphoSys|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debts AAPGV